Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population

S.A. McDonald, S.J. Hutchinson, P.R. Mills, S.M. Bird, C. Robertson, J.F. Dillon, A. Springbett, D.J. Goldberg, Chief Scientist Office (Funder), Medical Research Council (Funder)

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We estimated the extent of undiagnosed hepatitis C virus (HCV) infection in injecting drug users (IDUs) in Scotland. We used record-linkage to determine HCV diagnosis status for 41 062 current/former IDUs attending drug treatment and support services between 1 April 1995 and 31 March 2006; the extent of undiagnosed HCV infection was estimated by comparing the number HCV-diagnosed to the number HCV-infected (estimated from an unlinked anonymous testing survey of 2141 current/former IDUs). In all, 9145 IDUs (22%) were diagnosed HCV antibody-positive since first attendance at drug services (diagnosis rate of 33.6/1000 person-years,95% CI 32.7-34.4). By 31 March 2006, of the 19 632 current/former IDUs who had attended drug services and were determined to be living with HCV, an estimated 58% (95% CI 45-62)had not been HCV-diagnosed. It is essential that the deployment of resources for identifying at-risk IDUs with a view to offering antiviral therapy is guided by evidence.
LanguageEnglish
Pages393-402
Number of pages9
JournalInfection and Epidemiology
Volume138
DOIs
Publication statusPublished - Mar 2010

Fingerprint

Scotland
Virus Diseases
Drug Users
Hepacivirus
Population
Pharmaceutical Preparations
Hepatitis C Antibodies
Antiviral Agents
Therapeutics

Keywords

  • epidemiology
  • hepatitis C
  • injecting drug users (IDUs)
  • statistics
  • modelling science
  • mathematics

Cite this

McDonald, S. A., Hutchinson, S. J., Mills, P. R., Bird, S. M., Robertson, C., Dillon, J. F., ... Medical Research Council (Funder) (2010). Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population. Infection and Epidemiology, 138, 393-402. https://doi.org/10.1017/S0950268809990616
McDonald, S.A. ; Hutchinson, S.J. ; Mills, P.R. ; Bird, S.M. ; Robertson, C. ; Dillon, J.F. ; Springbett, A. ; Goldberg, D.J. ; Chief Scientist Office (Funder) ; Medical Research Council (Funder). / Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population. In: Infection and Epidemiology. 2010 ; Vol. 138. pp. 393-402.
@article{5622d19adbef4e9bacfe9ff897aec5d2,
title = "Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population",
abstract = "We estimated the extent of undiagnosed hepatitis C virus (HCV) infection in injecting drug users (IDUs) in Scotland. We used record-linkage to determine HCV diagnosis status for 41 062 current/former IDUs attending drug treatment and support services between 1 April 1995 and 31 March 2006; the extent of undiagnosed HCV infection was estimated by comparing the number HCV-diagnosed to the number HCV-infected (estimated from an unlinked anonymous testing survey of 2141 current/former IDUs). In all, 9145 IDUs (22{\%}) were diagnosed HCV antibody-positive since first attendance at drug services (diagnosis rate of 33.6/1000 person-years,95{\%} CI 32.7-34.4). By 31 March 2006, of the 19 632 current/former IDUs who had attended drug services and were determined to be living with HCV, an estimated 58{\%} (95{\%} CI 45-62)had not been HCV-diagnosed. It is essential that the deployment of resources for identifying at-risk IDUs with a view to offering antiviral therapy is guided by evidence.",
keywords = "epidemiology, hepatitis C, injecting drug users (IDUs), statistics, modelling science, mathematics",
author = "S.A. McDonald and S.J. Hutchinson and P.R. Mills and S.M. Bird and C. Robertson and J.F. Dillon and A. Springbett and D.J. Goldberg and {Chief Scientist Office (Funder)} and {Medical Research Council (Funder)}",
year = "2010",
month = "3",
doi = "10.1017/S0950268809990616",
language = "English",
volume = "138",
pages = "393--402",
journal = "Epidemiology and Infection",
issn = "0950-2688",

}

McDonald, SA, Hutchinson, SJ, Mills, PR, Bird, SM, Robertson, C, Dillon, JF, Springbett, A, Goldberg, DJ, Chief Scientist Office (Funder) & Medical Research Council (Funder) 2010, 'Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population' Infection and Epidemiology, vol. 138, pp. 393-402. https://doi.org/10.1017/S0950268809990616

Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population. / McDonald, S.A.; Hutchinson, S.J.; Mills, P.R.; Bird, S.M.; Robertson, C.; Dillon, J.F.; Springbett, A.; Goldberg, D.J.; Chief Scientist Office (Funder); Medical Research Council (Funder).

In: Infection and Epidemiology, Vol. 138, 03.2010, p. 393-402.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population

AU - McDonald, S.A.

AU - Hutchinson, S.J.

AU - Mills, P.R.

AU - Bird, S.M.

AU - Robertson, C.

AU - Dillon, J.F.

AU - Springbett, A.

AU - Goldberg, D.J.

AU - Chief Scientist Office (Funder)

AU - Medical Research Council (Funder)

PY - 2010/3

Y1 - 2010/3

N2 - We estimated the extent of undiagnosed hepatitis C virus (HCV) infection in injecting drug users (IDUs) in Scotland. We used record-linkage to determine HCV diagnosis status for 41 062 current/former IDUs attending drug treatment and support services between 1 April 1995 and 31 March 2006; the extent of undiagnosed HCV infection was estimated by comparing the number HCV-diagnosed to the number HCV-infected (estimated from an unlinked anonymous testing survey of 2141 current/former IDUs). In all, 9145 IDUs (22%) were diagnosed HCV antibody-positive since first attendance at drug services (diagnosis rate of 33.6/1000 person-years,95% CI 32.7-34.4). By 31 March 2006, of the 19 632 current/former IDUs who had attended drug services and were determined to be living with HCV, an estimated 58% (95% CI 45-62)had not been HCV-diagnosed. It is essential that the deployment of resources for identifying at-risk IDUs with a view to offering antiviral therapy is guided by evidence.

AB - We estimated the extent of undiagnosed hepatitis C virus (HCV) infection in injecting drug users (IDUs) in Scotland. We used record-linkage to determine HCV diagnosis status for 41 062 current/former IDUs attending drug treatment and support services between 1 April 1995 and 31 March 2006; the extent of undiagnosed HCV infection was estimated by comparing the number HCV-diagnosed to the number HCV-infected (estimated from an unlinked anonymous testing survey of 2141 current/former IDUs). In all, 9145 IDUs (22%) were diagnosed HCV antibody-positive since first attendance at drug services (diagnosis rate of 33.6/1000 person-years,95% CI 32.7-34.4). By 31 March 2006, of the 19 632 current/former IDUs who had attended drug services and were determined to be living with HCV, an estimated 58% (95% CI 45-62)had not been HCV-diagnosed. It is essential that the deployment of resources for identifying at-risk IDUs with a view to offering antiviral therapy is guided by evidence.

KW - epidemiology

KW - hepatitis C

KW - injecting drug users (IDUs)

KW - statistics

KW - modelling science

KW - mathematics

UR - http://www.scopus.com/inward/record.url?scp=76549112570&partnerID=8YFLogxK

U2 - 10.1017/S0950268809990616

DO - 10.1017/S0950268809990616

M3 - Article

VL - 138

SP - 393

EP - 402

JO - Epidemiology and Infection

T2 - Epidemiology and Infection

JF - Epidemiology and Infection

SN - 0950-2688

ER -